Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)

Objectives: During 2022, Omicron became the dominant SARS-CoV-2 variant in Europe. This study aims to assess the impact of such variant on severe disease from SARS-CoV-2 compared with the Delta variant in Italy. Methods: Using surveillance data, we assessed the risk of developing severe COVID-19 wit...

Full description

Bibliographic Details
Main Authors: Daniele Petrone, Alberto Mateo-Urdiales, Chiara Sacco, Flavia Riccardo, Antonino Bella, Luigina Ambrosio, Alessandra Lo Presti, Angela Di Martino, Emiliano Ceccarelli, Martina Del Manso, Massimo Fabiani, Paola Stefanelli, Patrizio Pezzotti, AnnaTeresa Palamara
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223000279